SanBio Co. Ltd.

SanBio Co. Ltd.
Stock Exchange Other OTC
EPS
$0.51
Market Cap
$1.65 B
Shares Outstanding
49.7 M
Public Float
-
SanBio Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY56.69
Market Cap
JPY182.36 B
Shares Outstanding
51.73 M
Public Float
26.71 M

Profile

Address
St. Luke Tower, 28/F
Tokyo Tokyo 104
Japan
Employees -
Website http://www.sanbio.jp
Updated 07/08/2019
SanBio Co., Ltd. engages in the development and sale of regenerative cells pharmaceuticals. It also provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded by Keita Mori and Toru Kawanishi in February 2001 and is headquartered in Tokyo, Japan.

Financials

View All

Toru Kawanishi
Chairman
Keita Mori
President & Representative Director